Imunon, Inc.
IMNN
$0.849
$0.01181.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -9.41M | 3.29M | 2.82M | -- | -7.73M |
| Gross Profit | 9.41M | -3.29M | -2.82M | -- | 7.73M |
| SG&A Expenses | 1.91M | 1.67M | 2.19M | 1.72M | 2.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.15M | 4.96M | 5.01M | 5.01M | 5.97M |
| Operating Income | -4.15M | -4.96M | -5.01M | -5.01M | -5.97M |
| Income Before Tax | -4.06M | -4.85M | -4.79M | -4.93M | -6.17M |
| Income Tax Expenses | -- | -- | -- | -- | -1.28M |
| Earnings from Continuing Operations | -4.06M | -4.85M | -4.79M | -4.93M | -4.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.06M | -4.85M | -4.79M | -4.93M | -4.89M |
| EBIT | -4.15M | -4.96M | -5.01M | -5.01M | -5.97M |
| EBITDA | -4.11M | -4.90M | -4.95M | -4.94M | -5.90M |
| EPS Basic | -0.28 | -0.34 | -0.51 | -0.52 | -0.52 |
| Normalized Basic EPS | -0.17 | -0.21 | -0.32 | -0.33 | -0.41 |
| EPS Diluted | -0.28 | -0.34 | -0.51 | -0.52 | -0.52 |
| Normalized Diluted EPS | -0.17 | -0.21 | -0.32 | -0.33 | -0.41 |
| Average Basic Shares Outstanding | 14.52M | 14.45M | 9.40M | 9.40M | 9.40M |
| Average Diluted Shares Outstanding | 14.52M | 14.45M | 9.40M | 9.40M | 9.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |